Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Massutí

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Chest|December 1, 1992
Malignant lymphoma in a patient with relapsing bronchiolitis obliterans organizing pneumoniaS Romero, C Martín, B Massutí, et al.
Medicina Clinica|September 28, 1991
[Rheumatoid arthritis and multiple neoplasms]J Ivorra, B Massutí, J Román, et al.
Radiologia|May 13, 2008
[The clinical and radiological characteristics and evolution of incidentally diagnosed pulmonary thromboembolism]P Tallón Guerola, J Arenas Jiménez, J de la Hoz Rosa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancerR Colomer, S Montero, A Lluch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
5-Fluorouracil, folinic acid, epidoxorubicin and cisplatin (FLEP) combination chemotherapy in advanced measurable gastric cancer. A phase II trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD)A Cervantes, A Villar-Grimalt, A Abad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2008
Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastasesS Benlloch, J M Galbis-Caravajal, C Alenda, et al.
Tumori|April 30, 1994
Phase II study with iododoxorubicin in measurable advanced colorectal adenocarcinoma. Effective rescue using weekly high-dose 5-fluorouracil (WFU). Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD), Work Group of SEOM (Spanish Medical Oncology Society)A Villar-Grimalt, E Aranda, B Massutí, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 1997
Modified weekly regimen with vinorelbine as a single agent in unresectable non-small cell lung cancerA Carrato, R Rosell, C Camps, et al.
Critical Reviews in Oncology/Hematology|January 1, 2010
First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD)J Sastre, E Aranda, C Grávalos, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II studyF Cardenal, M Domine, B Massutí, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Chest|December 1, 1992
Malignant lymphoma in a patient with relapsing bronchiolitis obliterans organizing pneumoniaS Romero, C Martín, B Massutí, et al.
Medicina Clinica|September 28, 1991
[Rheumatoid arthritis and multiple neoplasms]J Ivorra, B Massutí, J Román, et al.
Radiologia|May 13, 2008
[The clinical and radiological characteristics and evolution of incidentally diagnosed pulmonary thromboembolism]P Tallón Guerola, J Arenas Jiménez, J de la Hoz Rosa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancerR Colomer, S Montero, A Lluch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
5-Fluorouracil, folinic acid, epidoxorubicin and cisplatin (FLEP) combination chemotherapy in advanced measurable gastric cancer. A phase II trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD)A Cervantes, A Villar-Grimalt, A Abad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2008
Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastasesS Benlloch, J M Galbis-Caravajal, C Alenda, et al.
Tumori|April 30, 1994
Phase II study with iododoxorubicin in measurable advanced colorectal adenocarcinoma. Effective rescue using weekly high-dose 5-fluorouracil (WFU). Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD), Work Group of SEOM (Spanish Medical Oncology Society)A Villar-Grimalt, E Aranda, B Massutí, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 1997
Modified weekly regimen with vinorelbine as a single agent in unresectable non-small cell lung cancerA Carrato, R Rosell, C Camps, et al.
Critical Reviews in Oncology/Hematology|January 1, 2010
First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD)J Sastre, E Aranda, C Grávalos, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II studyF Cardenal, M Domine, B Massutí, et al.
Pageof 2